Access the summary of the Ovarian Cancer Drugs market report, featuring key insights, executive summary, market size, CAGR, growth rate, and future outlook.
Platinum drug-resistance in ovarian cancers mediated by anti-apoptotic proteins such as Bcl-xL is a major factor contributing to the chemotherapeutic resistance of recurrent disease. Consequently, con
Infinium MethylationEPIC BeadChip array data for HGSOC PH039 PDXs at baseline and treated with cycles of 100 mg/kg niraparib for 21 days for four treatment rounds and murine sample. Infinium Methylati